A robust Bayesian dose optimization design with backfill and randomization for phase I/II clinical trials. [PDF]
Qiu Y, Li M.
europepmc +1 more source
Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS
ABSTRACT Objective Corticospinal tract damage is common in people with MS, but the degree of clinical symptoms varies. We hypothesize that corticospinal tract lesions are more extensive and severe in people with MS with motor impairments in both upper and lower limbs.
Mathilde Liffran +13 more
wiley +1 more source
Simulation Analysis and Optimization Design of Dome Structure in Filament Wound Composite Shells. [PDF]
Zhou Y +6 more
europepmc +1 more source
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou +16 more
wiley +1 more source
BARD: A seamless two-stage dose optimization design integrating backfill and adaptive randomization. [PDF]
Zhao Y, Liu R, Lin J, Yuan Y.
europepmc +1 more source
Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants
ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree +9 more
wiley +1 more source
Multi-objective optimization design of oil spray cooling system for hairpin motor based on particle swarm optimization-backpropagation-non-dominated sorting genetic algorithm III. [PDF]
Liu Y +5 more
europepmc +1 more source
Early Recognition of Treatment‐Responsive Rapidly Progressive Dementia: The Modified STAM3mP Score
ABSTRACT Early identification of patients with treatment‐responsive rapidly progressive dementia (RPD) is important as early treatment improves outcomes. The STAM3P score identifies treatment‐responsive RPD using “high risk” presenting features. We optimized performance by adding a time component (i.e., dementia within 3 months) and validated the ...
R. W. van Steenhoven +16 more
wiley +1 more source
Gelation Performance of HPAM-Cr<sup>3+</sup> Gels for Reservoir Profile Control: The Impact of Propagation Distance and Optimization Design. [PDF]
Li M, Hu J, Wang X, Zhang G.
europepmc +1 more source

